Krystal Biotech buy Citigroup Inc.
Start price
27.02.24
/
50%
€152.00
Target price
27.02.25
€179.60
Performance (%)
-4.51%
Price
25.04.24
€145.15
Summary
This prediction is currently active. With a performance of -4.51%, the BUY prediction for Krystal Biotech by Citigroup_Inc_ is down slightly. This prediction currently runs until 27.02.25. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Krystal Biotech | -2.420% | -2.420% |
iShares Core DAX® | 2.594% | -1.861% |
iShares Nasdaq 100 | 3.553% | -2.064% |
iShares Nikkei 225® | 0.687% | -8.704% |
iShares S&P 500 | 2.209% | -1.988% |
Comments by Citigroup_Inc_ for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its price target raised by analysts at Citigroup Inc. from $160.00 to $195.00. They now have a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat